Real-world use of cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) PREVIOUSLY TREATED WITH DOCETAXEL: REGIONAL ANALYSIS
Data de publicación
2015Título da revista
Asia-Pacific Journal of Clinical Oncology
Tipo de contido
Publicación de congreso